|
|  |
Washington University in St. Louis News & Information > Faculty Experts at Washington University in St. Louis >
Frahm Family Professor of Organization and Strategy
Expertise: business strategy & public policy, intellectual capital management, new institutional economics, organizational economics, organizational theory, technology licensing, corporate strategy and policy, innovation, pharmaceutical manufacturing
Bio:
Nickerson's area of expertise includes corporate strategy and policy, economic policy, microeconomics, industrial organization, organizational economics, new institutional economics, intellectual capital management, technology licensing, organizational theory, human resource management, organizational behavior, and political economy. His collaborative reesearch with the U.S. Food and Drug Administration and the pharmaceutical industry is aimed at modernizing the regulation of pharmaceutical manufacturing and product quality. The study holds promise for reducing costs and expanding availability of life-saving medicines.
WUSTL Contact Information:
| Work: | (314) 935-6374 |
| Fax: | (314) 935-6359 |
|
|
Education:
-
B.S.M.E. at Worcester Polytechnic Institute
-
M.S.M.E. at University of California at Berkeley
-
M.B.A. at University of California at Berkeley
-
Ph.D. at University of California at Berkeley
| News Stories & Tip Sheets: |
Showing Stories 1 through 7 of 7.
- Show Home
|
|
Business research in practice
Washington University in St. Louis awards first Olin Award for most applicable research
April 7,
2008 -- Two professors at the Olin Business School are the winners of the first annual "Olin Award: Recognizing Research that Transforms Business." Jackson Nickerson, Ph.D. and Todd Zenger, Ph.D. will share the $10,000 honorarium in recognition of their research that examined the negative impact that social comparison, or envy, causes in the workplace.
|
Technology can help ease the pain when corporations change
The cozy side of IT
Oct. 19,
2007 --
 |
| Streaming video can make for a very authentic form of communication. |
While most businesses pay lip service to the importance of communication in managing change, few successfully do it. A business professor from Washington University in St. Louis says using the internet to stream short videos every week from the CEO is the first step toward smooth transitions.
|
Making R&D more cost effective
New framework for developing and supporting products could improve profitability as much as 30 percent
March 5,
2007 --
In dating — as in business — you don't want to be looking for a date when you're desperate; you want to find one before you become desperate. Business professors at Washington University in St. Louis have found that how firms manage their research and development (R&D) pipelines could mean the difference between always having products in the works and searching desperately for new goods. More...
|
Study finds both drug makers and F.D.A. could run a tighter ship
Pharmaceutical industry wastes $50 billion a year due to inefficient manufacturing
Oct. 9,
2006 --
The pharmaceutical industry could be wasting more than $50 billion a year in manufacturing costs alone, costs that could translate in to lower prices or greater research and development - according to findings of the largest empirical study ever performed of pharmaceutical manufacturing and the Food and Drug Administration monitoring policies. More...
|
WUSTL business professor studies when contracting work to outside sources is a bad idea
Outsourcing helps or hurts businesses, depending on how they're used
Feb. 2,
2006 --
People's suspicions about outsourcing are sometimes right; it is just a way for firms to save a buck. But when firms outsource IT projects or share resources with a supplier, they might be creating competitors who could steal customers or profit making ideas, says a professor from the Olin School of Business. Without knowing when it is appropriate to outsource, the financial impact could be quite harmful.
|
Prescription drugs
Canadian drug imports won't bring down the costs of drugs; would likely raise prices
Dec. 16,
2003 --  Despite the rejection of a provision to allow prescription drug imports from Canada in the Medicare bill passed by Congress, policymakers are still considering other bills that would allow the drug imports from North of the border. But Jackson Nickerson, a professor of organization and strategy at the Olin School of Business at Washington University in St. Louis, says that allowing the import of drugs from Canada would likely raise prices for both Canadians and U.S. consumers. Nickerson is currently engaged in a major research initiative with the Food & Drug Administration (FDA) and the pharmaceutical industry to improve the manufacturing process for drugs.
|
Pharmaceutical study
Business schools collaborate with FDA on drug manufacturing performance study
Sept. 17,
2003 --
The U.S. Food and Drug Administration will collaborate with Assistant Professor Jeffrey T. Macher of the Robert Emmett McDonough School of Business at Georgetown University and Associate Professor Jackson A. Nickerson of the Olin School of Business at Washington University in St. Louis as part of its strategic initiative to modernize the regulation of pharmaceutical manufacturing and product quality. Under the terms of the material transfer agreement with the FDA, Macher and Nickerson will conduct research and analysis to help the FDA identify the factors that predict manufacturing performance to further refine the agency's risk-based site selection model for inspections as well as its other efforts to target identified risks to pharmaceutical quality and strengthen its pharmaceutical compliance program.
|
Showing Stories 1 through 7 of 7.
- Show Home
|
|
|
| |
|
Download
Email this page
Print ready page